National Bank Of Canada Acasti Pharma Inc. Transaction History

National Bank Of Canada

  • $72.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023
BUY
$0.34 - $3.78 $5,141 - $57,161
15,122 Added 458.8%
18,418 $0
Q3 2022

Oct 13, 2022
SELL
$0.62 - $3.66 $9,375 - $55,346
-15,122 Reduced 82.1%
3,296 $2,000
Q1 2022

May 05, 2022
BUY
$0.94 - $1.43 $904 - $1,375
962 Added 5.51%
18,418 $22,000
Q4 2021

Jan 24, 2022
BUY
$1.07 - $2.01 $18,677 - $35,086
17,456 New
17,456 $22,000

About Acasti Pharma Inc.

ACST Quotes by TradingView
  • Ticker ACST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,610,100
  • Market Cap $146M
  • Description
  • Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
More about ACST
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email